Berg T - Search Results

1

Final safety and efficacy results from a 106 real-world patients registry with an ascites-mobilizing pump.

Stirnimann G, Berg T, Spahr L, Zeuzem S, McPherson S, Lammert F, Storni F, Banz V, Babatz J, Vargas V, Geier A, Engelmann C, Herber A, Trepte C, Capel J, De Gottardi A. Stirnimann G, et al. Among authors: berg t. Liver Int. 2022 Oct;42(10):2247-2259. doi: 10.1111/liv.15337. Epub 2022 Jul 25. Liver Int. 2022. PMID: 35686702 Free PMC article.

2

Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.

Sarrazin C, Berg T, Lee JH, Teuber G, Dietrich CF, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: berg t. J Hepatol. 1999 Jun;30(6):1004-13. doi: 10.1016/s0168-8278(99)80253-0. J Hepatol. 1999. PMID: 10406177

3

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U. Berg T, et al. Liver. 2000 Dec;20(6):427-36. doi: 10.1034/j.1600-0676.2000.020006427.x. Liver. 2000. PMID: 11169056 Clinical Trial.

4

[Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B].

Teuber G, Löhr HF, Kallinowski B, Berg T, Müller R, Zeuzem S. Teuber G, et al. Among authors: berg t. Dtsch Med Wochenschr. 2001 Feb 2;126(5):97-102. doi: 10.1055/s-2001-10880. Dtsch Med Wochenschr. 2001. PMID: 11225393 German.

5

Randomized, placebo-controlled, double-blind trial with interferon-alpha with and without amantadine sulphate in primary interferon-alpha nonresponders with chronic hepatitis C.

Teuber G, Berg T, Naumann U, Raedle J, Brinkmann S, Hopf U, Zeuzem S. Teuber G, et al. Among authors: berg t. J Viral Hepat. 2001 Jul;8(4):276-83. doi: 10.1046/j.1365-2893.2001.00297.x. J Viral Hepat. 2001. PMID: 11454179 Free PMC article. Clinical Trial.

6

Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.

Wasmuth HE, Werth A, Mueller T, Berg T, Dietrich CG, Geier A, Gartung C, Lorenzen J, Matern S, Lammert F. Wasmuth HE, et al. Among authors: berg t. Hepatology. 2004 Aug;40(2):327-34. doi: 10.1002/hep.20322. Hepatology. 2004. PMID: 15368437

7

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study.

Wiegand J, Buggisch P, Boecher W, Zeuzem S, Gelbmann CM, Berg T, Kauffmann W, Kallinowski B, Cornberg M, Jaeckel E, Wedemeyer H, Manns MP; German HEP-NET Acute HCV Study Group. Wiegand J, et al. Among authors: berg t. Hepatology. 2006 Feb;43(2):250-6. doi: 10.1002/hep.21043. Hepatology. 2006. PMID: 16440367 Clinical Trial.

8

Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin.

Snoeck E, Hadziyannis SJ, Puoti C, Swain MG, Berg T, Marcellin P, Zarski JP, Jorga K, Zeuzem S. Snoeck E, et al. Among authors: berg t. Liver Int. 2008 Jan;28(1):61-71. doi: 10.1111/j.1478-3231.2007.01603.x. Epub 2007 Oct 25. Liver Int. 2008. PMID: 17971091

9

The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.

Potthoff A, Wedemeyer H, Boecher WO, Berg T, Zeuzem S, Arnold J, Spengler U, Gruengreiff K, Kaeser T, Schuchmann M, Bergk A, Forestier N, Deterding K, Manns MP, Trautwein C; Hep-Net B/C Co-infection Study Group. Potthoff A, et al. Among authors: berg t. J Hepatol. 2008 Nov;49(5):688-94. doi: 10.1016/j.jhep.2008.03.028. Epub 2008 Apr 29. J Hepatol. 2008. PMID: 18490077 Clinical Trial.

10

Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin.

Lange CM, von Wagner M, Bojunga J, Berg T, Farnik H, Hassler A, Sarrazin C, Herrmann E, Zeuzem S. Lange CM, et al. Among authors: berg t. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1303-7. doi: 10.1097/MEG.0b013e32833de92c. Eur J Gastroenterol Hepatol. 2010. PMID: 20729742 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,213 results

Search Page